Shanghai Kehua Bio-Engineering Co Ltd
SZSE:002022
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Shanghai Kehua Bio-Engineering Co Ltd
SZSE:002022
|
CN |
|
22nd Century Group Inc
NASDAQ:XXII
|
US |
|
Nexteer Automotive Group Ltd
HKEX:1316
|
US |
|
W
|
Wintao Communications Co Ltd
SZSE:301139
|
CN |
|
Beigene Ltd
SSE:688235
|
KY |
Shanghai Kehua Bio-Engineering Co Ltd
Shanghai Kehua Bio-Engineering Co., Ltd. engages in the research, development, manufacture, and marketing business operation covering the whole industrial chain of vitro diagnostic device (IVD). The company is headquartered in Shanghai, Shanghai and currently employs 1,485 full-time employees. The company went IPO on 2004-07-21. The firm's products include in vitro diagnostic reagents, medical instruments and vacuum blood drawing supplies, among others. The firm operates its businesses in both domestic and overseas markets, with China as its main market.
Shanghai Kehua Bio-Engineering Co., Ltd. engages in the research, development, manufacture, and marketing business operation covering the whole industrial chain of vitro diagnostic device (IVD). The company is headquartered in Shanghai, Shanghai and currently employs 1,485 full-time employees. The company went IPO on 2004-07-21. The firm's products include in vitro diagnostic reagents, medical instruments and vacuum blood drawing supplies, among others. The firm operates its businesses in both domestic and overseas markets, with China as its main market.
